Notice of Special Interest (NOSI): Telehealth in Cancer Care

Grant Name
Notice of Special Interest (NOSI): Telehealth in Cancer Care
Funder
National Institutes of Health (NIH)
United States Department of Health and Human Services (HHS)
Country or Region
United States
Research Field
Cancer or Carcinogenesis
Health Care
Telemedicine
Deadline
March 8, 2024 (Expired)
Grant Size
Applicants considering an R1 application requesting a budget of $500,000 or more in any budget year must contact NCI before submitting an application.
Contact Info
Gurvaneet Randhawa, M.D., M.P.H., Scientific/Research Contact Gurvaneet.Randhawa@nih.gov
Kelly Blake, Sc.D., Scientific/Research Contact kelly.blake@nih.gov
Grant Number
NOT-CA-21-043
Description
The purpose of this Notice of Special Interest (NOSI) is to highlight the interest of the NCI’s Division of Cancer Control and Population Sciences in receiving investigator-initiated applications for conducting research on the use of telehealth in cancer-related care. Studies focused on populations that experience inequities in access to care and have worse cancer outcomes compared to the general population are strongly encouraged. This NOSI for R01 and R21 applications is a companion announcement to the RFA titled “Centers on Telehealth Research and Cancer-Related Care” (RFA-CA-21-029). Issued by: National Cancer Institute (NCI) Keywords Cancer or Carcinogenesis Health Care Telemedicine Upcoming Deadlines NoteThis notice applies to due dates on or after June 5, 2021, and subsequent receipt dates through March 8, 2024. Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice. PAR-21-190 PAR-21-035 PAR-19-348 PAR-19-350 Recurrence of Opportunity:This call is repeated once a year.

Funding resources

NIH General Instructions Download File
NIH Application Guide Open Link
Purdue Grant Writing Lab: Introduction to Grant Writing Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal Open Link

Quick share


Add deadline to calendar

March 8, 2024

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.


Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Related opportunities

International Bioethics Research Training Program (D43 Clinical Trial Optional)
Health Jun 06, 2024 12:00:00 AM EDT $230,000
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
Health Jun 06, 2024 12:00:00 AM EDT $230,000
Leading Engineering for America's Prosperity, Health, and Infrastructure
Science and Technology and other Researc... Sep 16, 2024 12:00:00 AM EDT $2,000,000
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
Health May 28, 2025 12:00:00 AM EDT $1,500,000
Strategic Prevention Framework – Partnerships for Success for States
Health Jun 05, 2025 12:00:00 AM EDT $1,250,000
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
Health Jun 06, 2025 12:00:00 AM EDT $295,924
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
Health Jun 06, 2025 12:00:00 AM EDT $295,924
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
MRFF 2022 Frontier Health and Medical Research Grant Opportunity
Health and Medical Research 31-Mar-2026 $400,000,000.00